Anti-drug antibodies in the current management of cancer | SpringerLink
Anti-drug antibodies - ProteoGenix
The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study | PLOS
Risk factors for anti‐drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial - Brun - 2022 - Journal of Internal Medicine - Wiley Online Library
Anti-Drug Antibody Assays with Next Generation Protein Sequencing
Anti-drug antibodies - ProteoGenix
Reported Frequency of Anti-Drug Antibodies in Clinical Trials of... | Download Table